Lu 38-012

Lu 38-012 is a potent and selective dopamine D 4 receptor antagonist which has been used in scientific research.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Lu 38-012 is a potent and selective dopamine D 4 receptor antagonist which has been used in scientific research. It has an affinity (K i ) for the dopamine D 4.2 receptor of 7.5 nM and showed 16-fold selectivity for this receptor over the dopamine D 2S receptor (K i = 120 nM). The drug had relatively little affinity for other dopamine receptors.

Affinities at other targets have also been reported. The drug produces hypolocomotion and reverses dextroamphetamine- and phencyclidine (PCP)-induced hyperlocomotion without producing catalepsy in rodents. Lu 38-012 partially substituted for clozapine in drug discrimination tests in rodents.

It was developed by Lundbeck and was first described in the scientific literature by 2006.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1363150386 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.